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Abstract 
Corneal cross-linking (CXL) using UVA irradiation with a riboflavin photosensitizer has grown 
from an interesting concept to a practical clinical treatment for corneal ectatic diseases globally, 
such as keratoconus. To characterize the corneal structural changes, existing methods such as 
X-ray microscopy, transmission electron microscopy (TEM), histology and optical coherence 
tomography have been used. However, these methods have various drawbacks such as invasive 
detection, the impossibility for in vivo measurement, or limited resolution and sensitivity to 
structural alterations. Here, we report the application of over-sampling nano-sensitive optical 
coherence tomography (nsOCT) method for probing the corneal structural alterations. The 
results indicate that the spatial period increases slightly after 30 minutes riboflavin instillation 
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but decreases significantly after 30 min UVA irradiation following the Dresden protocol. The 
proposed non-invasive method can be implemented using existing OCT system, without any 
additional components, for detecting nanoscale changes with the potential to assist diagnostic 
assessment during CXL treatment, and possibly to be a real-time monitoring tool in clinics.   
 
1. Introduction 
Corneal ectasia can severely impair vision, especially in the progressive form caused by the 
inherent structural weakness of the cornea. [1, 2] Keratoconus, the most common form of 
corneal ectasia affecting nearly 1 in 375 individuals globally, is an ocular disorder characterized 
by corneal degeneration due to corneal thinning that results in a focally decreased radius of 
corneal curvature and abnormal wavefront aberrations. [3-5] Keratoconus is a non-
inflammatory, progressive disease resulting in corneal instability in the structure. Sometimes it 
ultimately may require a corneal transplant. In recent years, a non-surgical keratoconus 
treatment, corneal cross-linking (CXL), was proved to be an effective way in halting the 
progression of keratoconus, meaning patients can avoid a corneal transplant. [6-9] Corneal 
cross-linking, using a combination of ultraviolet-A (UVA) light with 365 nm central 
wavelength and a photosensitizer (riboflavin, vitamin B2) for the procedure, shows a 
physiologic principle of tissue biomechanical modification. [10-12] CXL, which presents to be 
a minimally invasive treatment to stiffen the corneal stroma by strengthening the connections 
between collagen fibrils, was first approved by the U.S. FOOD and Drug Administration (FDA) 
in April 2016. [13] 
Despite being in clinical use for several years, some of the principles and underlying 
processes, such as the role of oxygen, the optimal treatment time and the way to monitor and 
assess the treatment, are still being worked out. [14, 15] The basic theory behind this approach 
is photo-polymerization, which leads to the creation of chemical bonds between collagens and 
proteoglycans and other proteins within the corneal stroma. Various researches have been 
  
3 
 
reported that the increase of tissue stiffness is dependent on the modifications of mechanical 
properties, which have a strong relationship with the ultrastructural alterations within the cross-
linked cornea, such as the changes of the characteristics of collagen fibrils. [16, 17] Detection 
of structural changes in corneal stroma during the cross-linking procedure would allow a more 
detailed investigation of healing processes or the efficacy of drugs. Characterizing the structural 
changes could allow in the future to improve optical monitoring and improve treatment methods 
to repair damages in the cornea. [18-22] Transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM) were used to study the relationship between mechanical 
behaviour and changes in the corneal ultrastructure after cross-linking in rabbit eyes. [23, 24] 
Although the nanoscale structure can be clearly imaged, these technologies will only suit the 
samples in vitro. Another option for detecting ultrastructure in the cornea is histology, which 
requires the anatomy of the tissue and therefore only applicable for ex vivo tissue. Some other 
methodologies including X-ray microscopy [25] and confocal microscopy [26, 27] also have 
various limitations, such as harmfulness from radiation damage, small imaging area or shallow 
imaging depth, causing difficulties in clinical eye diagnostics . 
Optical coherence tomography (OCT), first introduced by its name in 1991 for the 
visualization of alterations in the human eye by a team in Massachusetts Institute of Technology 
(MIT), originates from optical low-coherence interferometry and generates 2D or 3D cross-
sectional tomographic images by detecting the echo time delay and intensity of light which is 
reflected or back-scattered from internal structures in tissue. [28-30] OCT has proved to be of 
significant value in the visualization of transparent, weakly scattering media, such as the cornea, 
and obtained a substantial impact in the ophthalmology community. [15, 31-33] Efforts made 
in the last years in OCT technology have also made it possible to image highly scattering tissues, 
such as in dermatology, gastroenterology, oncology and interventional cardiology. Given its 
high-resolution, noninvasive, fast-speed and three-dimensional method, OCT fills the gap 
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between the optical microscopy and currently available clinical imaging methods considering 
both imaging resolution and depth.  
The interest in OCT for ophthalmic applications has rapidly increased in the past years. 
Refractive surgery on the cornea benefits very much from the existing OCT technology and is 
also used for phakic intraocular lens implantation. Laser-assisted in situ keratomileuses 
(LASIK) enhancement and lamellar keratoplasty are other applications using OCT technology. 
In all cases, OCT opened promising therapeutic and diagnostic options in both research and 
clinical applications in ophthalmology. The spatial and axial resolution of OCT is, however, 
also limited by the wavelength of the used light source and the used optical components.  
However, for specific treatments of the eye's cornea, the monitoring of cross-linking process 
requires image resolution in the nanometer range as documented using TEM and SEM. [23, 34] 
In this study, we have presented the application of over-sampling nano-sensitive optical 
coherence tomography (nsOCT), which is proposed to retain the high spatial frequency 
information in the interference spectra, to probe the structural alterations inside ex vivo bovine 
cornea during CXL treatment with nanoscale sensitivity. The capability of the proposed nsOCT 
method to detect nanoscale difference has been proved experimentally by distinguishing two 
periodic Bragg grating samples with known dimensional sizes. The investigation  of corneal 
cross-linking was performed using the Dresden protocol, which is the gold standard for the 
CXL treatment. The data of corneas were recorded and analyzed in three time nodes: 1) the 
epithelium removal, 2) a 30 min riboflavin instillation, and 3) a 30 min UVA irradiation. We 
present the over-sampling nsOCT B-scans and en face results at different corneal depths, 
showing a consistent consequence. The spatial periods of cornea increased slightly after 30 min 
riboflavin instillation but decreased significantly after 30 min UVA irradiation. The results 
suggest that the over-sampling nsOCT can be used to detect nano-sized structural changes 
valuable for corneal treatment methods. 
 
  
5 
 
2. Methods and Materials  
2.1. Principle and demonstration of the over-sampling nsOCT 
Scattering potential of a 3D object can be reconstructed from the distribution of the complex 
amplitude of the light scattered by the objective in far zone via 3D inverse Fourier transform. 
[35] Based on the theory of spectral encoding of spatial frequency (SESF) approach, [36-39] 
which was demonstrated for quantitative characterization of the structure with nanoscale 
sensitivity, nsOCT has been proposed to be a label-free depth-resolved sensing technique to 
probe structural changes at the nanoscale. [40-42] Later nsOCT has been used for study of the 
nanometer-scale structural changes of the human tympanic membrane in otitis media. [43] 
Recently a version of the nsOCT based on correlation between axial spatial frequency profiles 
has been published. [44] In this study, oversampling is used to increase the number of points in 
the reconstructed axial spatial frequency/period profiles. In conventional OCT, high-frequency 
information has been killed during the inverse Fourier transform, and the axial resolution is 
limited in micron level depending on the spectral bandwidth of the light source.  
The nsOCT method carries the spectrally encoded axial spatial period from the k-space to 
the reconstructed object space by encoding each axial spatial frequency with one particular 
wavelength. The signal processing for nsOCT is illustrated in a flowchart in Figure 1. To realize 
over-sampling nsOCT, we first obtain the processed interference spectra after basically 
preliminary modifications, including k-space linearization, background noise removal, 
apodization, and dispersion compensation. Then the processed spectra are decomposed into 
several sub-bands using Tukey windows as for nsOCT imaging. To minimize the spatial 
frequency range for one sub-band, we then oversample the spatial frequencies by shifting the 
window with the same width, i.e. the starting point for each processing shifts along spatial 
frequency, as illustrated in Figure 1 (a). The FFT of each sub-band signal has been performed 
to get the amplitude along all the imaging depths for one spatial frequency range, as shown in 
Figure 1(b). By combining all the over-sampling spatial profiles, it is possible to reconstruct 
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the dominant structural size of each voxel by counting the medium spatial periods with the 
maximum energy contribution, as indicated in Figure 1(c). 
The collected complex amplitudes of the spectrum are converted to complex amplitudes of 
spatial frequencies ( zV ) based on the following relation:  
2
z
n
V

=                                                                      (1) 
where n  is the refractive index, and   is the wavelength. The spatial periods ( zH  ) of the 
structure can be expressed as follows:  
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The nsOCT image can be then constructed by mapping the corresponding dominant spatial 
period to each voxel with an optimized threshold.  
For further experimental validation of the proposed nsOCT method, we used two reflection 
Bragg gratings with periodicities of 431.6 nm and 441.7 nm (Corp. OptiGrate, Florida, United 
States) as the samples. Each periodic layer was fabricated with sinusoidal refractive index varies 
1.483 ± 0.001. No variation in periodicity vs time if temperature of usage is <400°C (the period 
will be stable better than 1 pm). With the purpose of mimicking an imaging condition similar 
to real tissue, a two-layer plastic tape were placed on the top of the Bragg gratings and a tissue 
paper, as shown in Figure 2(a). 
Figure 2(a) and 2(b) show the conventional intensity-based OCT B-scan and en face images, 
where the structural difference between the Bragg gratings cannot be recognized since the high-
frequency information is not available using general OCT processing. While following the 
proposed nsOCT method, both the nsOCT B-scan and en face images were constructed with 
spatial periods mapping as presented in Figure 2(c) and (d), easily visualizing the nanometer 
structural difference (~10 nm) between two Bragg gratings. The spatial periods of the tape and 
tissue paper are quite diffused with various values as the structural sizes of them are randomly 
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distributed. From the proof-of-concept demonstrations, we successfully verify that the nsOCT 
method is a promising way to sense nanoscale structural alterations along the depth axis. 
Further, to clarify the difference between over-sampling nsOCT and the previous nsOCT 
method, we have added both simulation and experiment results.  In the simulation, we produce 
seven samples with different axial periodicities of 425 nm, 428 nm, 431 nm, 434 nm, 437 nm, 
440 nm and 443 nm. As shown in Figure 3, the structural difference of 3 nm can be 
distinguished by the over-sampling nsOCT. However, nsOCT without over-sampling can only 
detect the difference of 6 nm but cannot distinguish 3 nm difference. In the experiment, we still 
use the Bragg gratings for the demonstration.  For the Bragg grating with 431.6 nm periodicity, 
we measure 430.4 nm (error: 1.2 nm) by over-sampling nsOCT while  428.2 nm (error: 3.4 nm)  
by the previous nsOCT method, as shown in Figure 4. It also demonstrates that nsOCT after 
over-sampling can provide a higher measurement accuracy. Another result of the Bragg grating 
with 441.7 nm periodicity is attached in the supplementary files Figure S1, also showing an 
improved sensitivity after over-sampling process. 
 
2.2. Ex vivo bovine corneal cross-linking experiment 
In the CXL experiments, we chose bovine corneas for more consistent sample quality from the 
local abattoir. The bovine eyes were harvested in the evening of slaughter from a local abattoir 
(Athenry Quality Meats Ltd, County Galway, Ireland) within 2 hours post mortem and stored 
at 4 °C. The abattoir granted permission for the eyes to be used in research. Eye globes with 
intact epithelium and clear cornea were selected for the ex vivo studies. As it is an epi-off cross-
linking treatment, we first removed the epithelium with a stainless-steel spatula. The CXL 
process was performed in a dark environment using riboflavin (MedioCROSS M, 0.1% 
Riboflavin, 1.1% HPMC) as the photosensitizer and final irradiation with UV-A light (UV-
XTM 2000, IROC Innocross, Zurich, Switzerland) with a illumination spot size of 9.5 mm, 3.0 
mW/cm2 intensity, and energy dose of 5.4 J/cm2.  
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Following the Dresden protocol, which is the current gold standard of CXL treatment, we 
conducted the structural detections at the three treating steps including immediately after 
epithelial removal, after 30 min riboflavin instillation, and after 30 min UVA irradiation with a 
further continuous installation every 2 minutes.  
For the data acquisition, a commercial spectral-domain optical coherence tomography 
(SDOCT) system (Telesto Ⅲ, Thorlabs, Inc. New Jersey, United States) with an objective lens 
LSM03 (NA=0.055, lateral resolution=13 μm) was used in our experiments. This high-
resolution OCT system, operating at the central wavelength of 1300 nm with sensitivity 96 dB 
@76kHz rate, can reach an axial resolution of 5.5 μm and imaging depth of 3.6 mm in air. 
 
3. Results 
We used a laser scanning confocal microscopy system (FV 3000, Olympus ) to investigate 
the differences between the untreated and treated corneas. We used a 405 nm excitation 
wavelength and an objective lens with an NA of 0.85 (UPLSAPO 20XO) for the imaging 
process. The confocal microscopy images of the virgin and treated corneas are presented in 
Figure 5. The virgin corneas consisted of highly reflective and well-demarcated cell nuclei with 
an oval shape, indicated by white arrows. Neither keratocyte processes nor collagen fibers could 
be visualized. However, the crosslinked cornea was populated with some reflective 
interconnected stellate structures. These structures contained elongated nuclei and keratocyte 
apoptotic bodies. The confocal microscope images show that the corneal crosslinking has 
occurred during the CXL treatment. 
Figure 6(a, c, e) shows the intensity-based OCT B-scans for the three processing steps, 
respectively. However, the conventional OCT images cannot identify any changes smaller than 
the resolution limit and no structural differences inside corneas can be identified. Here, we 
applied the proposed nsOCT method for analyzing the structural responses during CXL 
treatment, showing B-scans with spatial periods mapping, as presented in Figure 6(b, d, f). The 
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nsOCT B-scans show that there are no observable structural alterations between the virgin 
cornea and the cornea after 30 min riboflavin instillation, only presenting a minor increase after 
riboflavin immersion. But the spatial periods had an obvious decrease after 30 min UVA 
irradiation, meaning that the structural size decreased significantly after the CXL treatment. In 
Figure 6(f),  the spatial periods after CXL process were clearly detected to be smaller by several 
nanometers compared to Figure 6(b, d). 
To quantitatively demonstrate the structural variations associated with CXL treatment, we 
also investigated the histograms and boxplots of spatial period distributions for B-scans at all 
the three steps. Figure 7(a, b, c) indicates the spatial period results for one of the bovine corneas. 
The mean spatial periods of the virgin cornea, the cornea after 30 min riboflavin instillation and 
after 30 min UVA irradiation were measured to be 657.1 nm, 658.1 nm and 649.6 nm, 
respectively, illustrating the slightly larger spatial size after riboflavin immersion but 
substantially smaller after the CXL procedure. In the meantime, the histograms of spatial period 
distributions also show that the treated cornea has shifted to be smaller structural sizes. 
Further, we have conducted a series of repeating experiments on different bovine eyes under 
the same CXL protocol and signal processing. Analyzing the experimental data of ten bovine 
eyes associated with CXL treatment, we made a summary on both the intensity and spatial 
period shifts as presented in Table 1 and Table 2, respectively. We found that the intensity 
values fluctuated both negatively and positively with no continuous change in one single way, 
i.e., it is not possible to detect the variations during the CXL process by conventional intensity-
based OCT. Additionally, we included the intensity histograms of the virgin cornea, the cornea 
after 30 min of riboflavin instillation, and the treated cornea in Figure S2. Again, we cannot 
observe any obvious intensity shifts between them.  
Summarizing all the experimental sets using the proposed over-sampling nsOCT method, 
we evaluated that the spatial period has changed from 653.9± 1.7 nm (mean ± standard 
deviation) of the virgin corneas to 647.5± 3.3 nm of the treated corneas. The spatial periods 
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inside the cornea have decreased -6.4± 2.8 nm with the percentage of (-0.98± 0.43)% after CXL 
treatment. Furthermore, one can also notice that there is a consistent decrease of spatial period 
for all the bovine corneas in the experiments, providing a reasonably convincing verification of 
the nanoscale structural changes associated with the CXL treatment. 
The acquisition of 3D volumetric data was used to obtain en face images along with different 
imaging depths. Each en face image was obtained over an area with 2 mm x 2 mm size and 400 
x 400 A-lines. The treatment was performed with the same protocol as described above. The 
conventional OCT en face images (Figure 8a-c) is not able to resolve any features that could 
indicate any changes due to the CXL procedure. Nonetheless, the nsOCT en face images could 
visualize the nanoscale alterations especially between the virgin cornea and cross-linked cornea, 
showing a minor spatial period after the treatment, as indicated in Figure 8(d, e, f). In the result, 
the mean spatial periods of en face data of the virgin cornea, the cornea after 30 min riboflavin 
instillation and the cross-linked cornea were calculated to be 653.2 nm, 654.3 nm and 648.6 nm, 
respectively. To evaluate the change of the nsOCT en face images at different depths, a series 
of scans at increasing depth were assembled in Video S1. 
Figure 9 shows the spatial period (Y-Axis) along a depth (X-Axis) from 200 to 770 µm 
computed at depth intervals of 38 µm step width. The change of the spatial period for each 
treatment step is easily recognizable in Figure 9. The spatial periods for a virgin bovine cornea 
(red circles) are consistently smaller than those for a cornea treated with riboflavin (yellow 
squares). A significant change occurs after the 30 minutes of UVA irradiation and the values of 
the spatial periods reduce by about 3 nm from 652 nm to 649 nm. 
Based on the values plotted in Figure 9, a paired t-test was performed (samples size ten per 
group) which confirmed the high significance (p<10-4) between the virgin corneas and the group 
after 30 min riboflavin instillation.  The p-value test for spatial changes between the virgin and 
CXL treated corneas provided an even larger significance p<10-13. 
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4. Discussion 
The experimental results of Bragg gratings with known structural sizes have demonstrated 
the feasibility of the over-sampling nsOCT method to distinguish the nanoscale structural 
alterations in both B-scan and en face images. In the study of ex vivo bovine corneas associated 
with CXL treatment, both the conventional intensity-based OCT images and the corresponding 
nsOCT images were constructed for the virgin cornea after epithelial removal, the cornea after 
30 min riboflavin instillation and after 30 min UVA irradiation. From the conventional OCT 
images, we can hardly recognize the internal structural changes of the cornea due to the limited 
axial resolution of several micrometers. Nonetheless, our investigation using the nsOCT 
modality could detect the ultrastructural variations inside the cornea during CXL treatment, 
showing that the spatial periods slightly increased after 30 min riboflavin instillation but 
significantly decreased after 30 min UVA irradiation.  
According to the existing reports, the structural size inside the cornea should decrease after 
riboflavin absorption due to the dehydration from the hypertonic photosensitizer solution. In 
our study, we found an increased spatial period after 30 min riboflavin instillation in a dark 
circumstance. We think the reason why we got opposite results with TEM or SEM method is 
because of the increase of refractive index inside cornea after riboflavin immersion. In OCT 
system, we detect the optical path difference that depends on both the physical structural size 
and the refractive index of sample. The minor increment of the spatial period after 30 min 
riboflavin instillation may be related to the higher refractive index of riboflavin compared to 
the cornea itself. The mean refractive index inside the stroma will hereby increase when 
riboflavin penetrates inside the cornea, resulting in a larger spatial period. 
To investigate the interfibrillar distance and fibril diameter changes of corneal stroma after 
CXL treatment, a few methods, such as TEM, SEM, and X-ray imaging, have been discussed 
in the previous literature. T. Sibillano et al [25] studied on the ex vivo bovine corneas using 
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small-angle X-ray scattering (SAXS) microscopy and revealed that the interfibrillar distance 
decreased from ~62 nm (virgin cornea) to ~56 nm (treated cornea). The results also concluded 
the decrease in the fibril shell thickness from ~11 nm to ~9 nm after CXL treatment because of 
the effect of cross-linking within proteoglycan core proteins, resulting in a decreased spatial 
periods. The similar results on structural changes associated with CXL process were also 
reported by Ho, Leona TY et al, [45] Freund et al [46] and Cheng et al, [47], showing a good 
agreement with the proposed nsOCT method. More results have also been reported on the rabbit, 
porcine and sheep corneas. For instance, Sally Hayes [20, 24] found that the fiber diameter of 
in vitro porcine cornea increased while the interfibrillar spacing decreased. Ex vivo, CXL 
treatment on sheep corneal tissue samples was associated with slight decreases of collagen 
intermolecular spacing. 
Further, dehydration may be one of the factors contributing to the structural changes during 
CXL treatment, especially for ex vivo samples. Therefore, to ensure that the structural 
alterations are induced by corneal cross-linking treatment other than some other factors, such 
as dehydration, a control experiment was arranged. The bovine eye was treated in the same 
CXL procedure as mentioned before, except that half of the cornea was blocked from the UVA 
illumination. 
The virgin cornea was imaged immediately after removing the epithelium, as Figure 10(a) 
shows the intensity-based OCT image and Figure 10(b) presents the nsOCT image. Then the 
riboflavin was dropped on the entire cornea for 30 minutes in a dark circumstance. In the last 
step, different from the previous process, a blocking long pass filter was used to stop the UVA 
illumination in the right half of the cornea. As presented in Figure 10(c), the CXL treatment 
will only occur in the left half of the cornea, as the UVA light cannot reach the right half. We 
calculated that the spatial period of the left half was 647.9 nm while the right half is 653.6 nm, 
also showing a decreased spatial period after CXL treatment. The corresponding nsOCT image, 
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shown in Figure 10(d), demonstrated the nanoscale structural differences between left and right 
half of the same cornea. 
 
5. Conclusion 
In this study, we reported that the nano-structural changes inside ex vivo bovine cornea 
associated with CXL treatment can be clearly detected by the proposed over-sampling nsOCT 
method. Multipe experiments on several groups of samples have consistently shown that the 
spatial periods inside corneal stroma increased slightly after 30 minutes riboflavin instillation 
but decreased significantly after 30 min UVA irradiation. En face nsOCT images at different 
corneal depths have also confirmed the consistent consequences, demonstrating the nanoscale 
structural decrease after the CXL treatment.   
To the best of our knowledge, there is no clear tools or procedures to follow up with the 
patient corneal monitoring during CXL treatment. The currently preferred procedure is the 
epithelium mapping which reflects the behaviour of the other layers of the cornea, but it is not 
capable of the epi-off surgery or real-time ultrastructural inspection. The proposed method can 
be implemented using the existing OCT system, without any additional components, therefore 
it can be relatively straightforward to be applied in in vivo tissues and translated to clinical use 
as a novel imaging system. Due to its fast, non-invasive detecting method and nanoscale 
sensitivity, this unique technology is potential to be an indicator in diagnostic assessment 
associated with CXL treatment, and possibly to be a real-time monitoring tool in clinics as a 
fast way to receive feedback from patient’s tissue. Future work will aim to implement this 
method for in vivo corneal detections associated with CXL treatment, including monitoring the 
nanoscale structural variations at different treating step and also the postoperative assessment.  
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SUPPORTING INFORMATION  
Additional Supporting Information may be found online in the supporting information tab for 
this article. 
Figure S1: Experimental results of the Bragg grating with axial periodicity of 441.7 nm by 
previous nsOCT and the over-sampling nsOCT method. 
Figure S2: Intensity histograms of the virgin cornea, the cornea after 30 min of riboflavin 
instillation, and the treated cornea. 
Video S1: Over-sampling nsOCT en face images of the virgin cornea and treated cornea at 
different depths. 
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FIGURES AND TABLES 
 
 
Figure 1.  Flowchart for the over-sampling nsOCT signal processing. (a) Decompose axial 
spatial frequencies into multiple sub-bands and shift the dividing windows for over-sampling 
the spatial frequencies. (b) FFT of each sub-band and acquire the amplitude along different 
depths in each particular spatial frequency range. (c) Reconstruct and sum up all the spatial 
period profiles by taking the energy contribution of each sub-band and then obtain the dominant 
structural size for each voxel. 
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Figure 2.  Experimental validation of the over-sampling nsOCT method by both B-scan and en 
face images. The two periodicity-different Bragg gratings and a tissue paper were covered under 
a two-layer tape. (a, b) Conventional intensity-based OCT B-scan and en face image at the 
depth marked by the dashed line. (c, d) The corresponding nsOCT B-scan and en face image 
with spatial periods mapping, visualizing the nanoscale structural differences between the 
samples. The color bar presents the spatial periods with unit nanometer. 
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Figure 3.  Simulation results of nsOCT without and with over-sampling. (a) nsOCT without 
over-sampling can detect the difference of 6 nm but cannot distinguish 3 nm difference, (b) 
nsOCT with over-sampling is able to distinguish the structural difference of 3 nm. 
 
 
Figure 4.  Experimental results of the Bragg grating with axial periodicity of 431.6 nm. (a) The 
nsOCT without over-sampling presents a 428.2 nm structural size. Error is 3.4 nm. (b)The 
nsOCT with over-sampling shows a 430.4 nm structural size. Error is 1.2 nm. The color bar 
presents the spatial periods with unit nanometer. 
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Figure 5.  Confocal microscopy images of the virgin and treated cornea. (a) The virgin corneas 
consists of highly reflective and well-demarcated cell nuclei with an oval shape, indicated by 
white arrows. (b) The treated cornea is populated with some reflective interconnected stellate 
structures, containing elongated nuclei and keratocyte apoptotic bodies. The scale bar is 50 μm. 
 
 
Figure 6.  B-scans of ex vivo bovine cornea during CXL treatment at three treating steps. (a, b) 
Both conventional OCT and nsOCT images acquired immediately after epithelial removal. (c, 
d) Images constructed after 30 min riboflavin instillation and (e, f) after 30 min UVA irradiation 
while finishing the treatment. The color bar presents the spatial periods with unit nanometer. 
 
 
Figure 7.  Histogram and boxplot of spatial period distributions inside cornea associated with 
CXL treatment. (a) Virgin cornea with the mean spatial period of 657.1 nm. (b) The cornea 
after 30 minutes riboflavin instillation with the mean value of 658.1 nm. (c) The crosslinked 
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cornea with the mean value of 649.6 nm, with the histogram showing a shift towards lower 
spatial period compared with (a) and (b). 
 
 
Figure 8.  Conventional OCT and nsOCT en face images at the three key treating steps during 
CXL treatment. (a, b, c) Conventional intensity-based OCT en face images of the cornea after 
epithelium removal, after 30 min riboflavin instillation and after 30 min UVA illumination, 
respectively. (d, e, f) The corresponding nsOCT en face images with spatial period mapping, 
presenting the nanoscale structural alterations. The en face images were constructed at the depth 
of ~500 μm. The color bar presents the spatial periods with unit nanometer. 
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Figure 9.  Mean spatial periods at various corneal depths for the virgin cornea, the cornea after 
30 min riboflavin instillation and the cross-linked cornea, indicated by red, yellow and blue 
color, respectively. 
 
 
Figure 10.  A control experiment with the cornea half blocked from UVA irradiation. (a, b) 
Conventional intensity-based OCT and nsOCT images of the virgin cornea. (c) The 
conventional OCT image of the half cross-linked cornea using a UVA irradiation block on the 
right half. (d) The corresponding nsOCT image of the half cross-linked cornea, illustrating the 
nanoscale structural difference between left half and right half in the same B-scan. The color 
bar presents the spatial periods with unit nanometer. 
 
TABLE 1. The intensity changes between virgin cornea and cross-linked cornea during the CXL 
treatment 
Bovine 
corneas 
Mean intensity values (dB) 
Virgin Treated Shift Percentage 
S1 35.86 35.57 -0.29 -0.81% 
S2 35.99 35.31 -0.68 -1.89% 
S3 35.58 34.96 -0.62 -1.74% 
S4 36.01 36.55 +0.54 +1.50% 
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S5 35.90 35.36 -0.54 -1.50% 
S6 35.62 36.01 +0.39 +1.09% 
S7 35.88 36.13 +0.25 +0.70% 
S8 35.79 35.99 +0.20 +0.56% 
S9 36.03 35.69 -0.34 -0.94% 
S10 35.86 35.32 -0.54 -1.50% 
Mean 35.85± 0.15 35.69± 0.48 -0.16± 0.46 (-0.45± 1.23)% 
 
TABLE 2. The spatial period changes of virgin cornea and cross-linked cornea during the CXL 
treatment 
Bovine 
corneas 
Mean spatial periods (nm) 
Virgin Treated Shift Percentage 
S1 657.1 649.6 -7.5 -1.14% 
S2 652.1 638.5 -13.6 -2.09% 
S3 656.3 649.2 -7.1 -1.08% 
S4 654.3 648.1 -6.2 -0.95% 
S5 653.2 649.6 -3.6 -0.55% 
S6 651.7 646.9 -4.8 -0.74% 
S7 653.6 648.9 -4.7 -0.72% 
S8 653.9 647.3 -6.6 -1.01% 
S9 654.3 649.6 -4.7 -0.72% 
S10 652.6 647.3 -5.3 -0.81% 
Mean 653.9± 1.7 647.5± 3.3 -6.4± 2.8 (-0.98± 0.43)% 
 
Graphical Abstract 
 
We report the application of over-sampling nano-sensitive optical coherence tomography 
method for monitoring the nanoscale structural changes inside cornea during corneal cross-
linking (CXL) treatment. The proposed method can be implemented using the existing OCT 
system, without any additional components, to achieve fast, non-invasive and nanoscale 
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sensitivity detection. It can be an indicator in diagnostic assessment associated with CXL 
treatment, and possibly to be a real-time monitoring tool in clinics. 
 
